Research Paper Volume 13, Issue 3 pp 3969—3993
Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma
Figure 6. Relationship between the expression of candidate genes and clinicopathological parameters of HCC patients in TCGA (UALCAN). (A–D) Transcriptional expression of candidate genes in HCC tissues and adjacent normal liver tissues. (E–H) Transcriptional expression of candidate genes in different cancer stages of HCC patients. (I–L) Transcriptional expression of candidate genes in different tumor grades of HCC patients. HCC, Hepatocellular Carcinoma; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.